Clinical Research and Medical Information on the RCP Test
What is the RCP Test?
The RCP Test is a patented blood test for the possible presence of ovarian, uterine, and cervical cancer in women. Designed to identify distinctive protein patterns in the blood that can reflect the presence of estrogen-related cancers, the test offers patients and doctors a unique early detection option for women.
What is the RCP Biomarker?
Riboflavin, or vitamin B-2, is an essential water-soluble vitamin that is critical for cellular metabolism of protein, fat, and carbohydrates. Riboflavin Carrier Protein (RCP) transports riboflavin to where it’s needed throughout the body.
RCP is modulated by estrogen and is a growth and development protein made in the liver. Estrogen is a hormone that is essential for reproduction and the normal growth and development of breast tissues. It plays an important role in childbearing and helps regulate a woman's menstrual cycles. Estrogen also promotes strong bones and cardiovascular health.
However, lifetime exposure to estrogen is associated with an increased risk for breast cancer among women. Because of the relationship between RCP and estrogen, recent research has shown that RCP is an excellent indicator, or biomarker, of both the presence and the stage of the disease.
